Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ken Uematsu"'
Autor:
Mayumi Ichikawa, Ken Uematsu, Natsuko Yano, Masayoshi Yamada, Takashi Ono, Shohei Kawashiro, Hiroko Akamatsu, Yasuhito Hagiwara, Hiraku Sato, Kenji Nemoto
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Cancer treatment requires a multidisciplinary approach. Therefore, multidisciplinary team meetings (MDTMs) have been widely used to determine the direction of treatment. However, no standard provisions exist for conducting MDTMs,
Externí odkaz:
https://doaj.org/article/68c16c3a95294f729e2ca3777febda1a
Autor:
Tomoyuki Nakamura, Masaru Tomita, Naoki Horikawa, Masatoshi Ishibashi, Ken Uematsu, Teruyuki Hiraki, Toshi Abe, Naohisa Uchimura
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 2, Pp 168-178 (2021)
Abstract Aim Approximately one‐third of patients with major depressive disorder develop treatment‐resistant depression. One‐third of patients with treatment‐resistant depression demonstrate resistance to ketamine, which is a novel antidepress
Externí odkaz:
https://doaj.org/article/7621f290b58c4609867dd1417adb5f56
Autor:
Yasuhito Hagiwara, Shohei Kawashiro, Takayuki Kanai, Hikaru Souda, Yuya Miyasaka, Kenji Nemoto, Mayumi Ichikawa, Mayumi Harada, Hiroko Akamatsu, Masayoshi Yamada, Natsuko Yano, Rei Matsueda, Hiraku Sato, Ken Uematsu
Publikováno v:
Journal of Radiation Research
We aimed to predict the minimum distance between a tumor and the gastrointestinal (GI) tract that can satisfy the dose constraint by creating simulation plans with carbon-ion (C-ion) radiotherapy (RT) and photon RT for each case assuming insertion of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d703e2977ed15cfc9bc24acf1c672c
https://doi.org/10.1093/jrr/rrab047
https://doi.org/10.1093/jrr/rrab047
Autor:
Toshi Abe, Teruyuki Hiraki, Tomoyuki Nakamura, Naohisa Uchimura, Masaru Tomita, Ken Uematsu, Naoki Horikawa, Masatoshi Ishibashi
Publikováno v:
Neuropsychopharmacology Reports
Aim Approximately one‐third of patients with major depressive disorder develop treatment‐resistant depression. One‐third of patients with treatment‐resistant depression demonstrate resistance to ketamine, which is a novel antidepressant effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::985d119ccb1a93332c6432edcb838724
https://doi.org/10.1002/npr2.12165
https://doi.org/10.1002/npr2.12165
Autor:
Fiammetta Cosci, Sara Romanazzo, Giovanni Mansueto, Petra Rontani, Michelle N. Levitan, Roseane D. Halkjœr-Lassen, Laiana A. Quagliato, Tomoyuki Nakamura, Ken Uematsu, Antonio E. Nardi, Misari Oe, Virginie-Anne Chouinard, Guy Chouinard
Publikováno v:
Journal of Clinical Psychopharmacology, 42(1), 17-22. LIPPINCOTT WILLIAMS & WILKINS
Background Withdrawal syndromes can occur after dose reduction or discontinuation of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Few measurement instruments are available to assess them: Di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875c81526d30b1cc77043259a0fa309b
https://cris.maastrichtuniversity.nl/en/publications/f08a5f25-586c-4a10-bbcd-15001f085f9c
https://cris.maastrichtuniversity.nl/en/publications/f08a5f25-586c-4a10-bbcd-15001f085f9c
Autor:
Myriam Heiman, Ken Uematsu, Julio C. Padovan, Akinori Nishi, Marina Zelenina, Anita Aperia, Brian T. Chait, Paul Greengard
Publikováno v:
PMC
Metabotropic glutamate receptor 5 (mGluR5) regulates excitatory post-synaptic signaling in the central nervous system (CNS) and is implicated in various CNS disorders. Protein kinase A (PKA) signaling is known to play a critical role in neuropsychiat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1cc28288cae51dbc66bb8ed4e461ea3
https://europepmc.org/articles/PMC4359654/
https://europepmc.org/articles/PMC4359654/
Autor:
Paul Greengard, Linda C. Hsieh-Wilson, Ken Uematsu, Marie Futter, Akinori Nishi, Angus C. Nairn, Hideho Higashi, Hisao Maeda
Publikováno v:
Journal of neurochemistry. 95(6)
Spinophilin is a protein phosphatase-1 (PP-1)- and actin-binding protein that is enriched in dendritic spines. Phosphorylation of the actin-binding domain of rat spinophilin at one or more sites by protein kinase A (PKA) inhibits actin binding. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa9569fbaf6208895b31dddac43d1786
https://pubmed.ncbi.nlm.nih.gov/16300646
https://pubmed.ncbi.nlm.nih.gov/16300646
Autor:
Paul Greengard, Marie Futter, Angus C. Nairn, Stewart A. Bullock, Akinori Nishi, Hugh C. Hemmings, Yong Kim, Ken Uematsu
Spinophilin is a protein that binds to protein phosphatase-1 and actin and modulates excitatory synaptic transmission and dendritic spine morphology. We have identified three sites phosphorylated by ERK2 (Ser-15 and Ser-205) and cyclin-dependent PK 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a9c085dc20b3bbb7c43e800b67f6a7
https://europepmc.org/articles/PMC552943/
https://europepmc.org/articles/PMC552943/
Publikováno v:
Neuroscience Research. 71:e211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b167d52b01734c67244767c7c5ca7043
https://doi.org/10.1016/j.neures.2011.07.918
https://doi.org/10.1016/j.neures.2011.07.918
Publikováno v:
Neuroscience Research. 58:S197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d40040c45ae0188996ca7205b52de3d
https://doi.org/10.1016/j.neures.2007.06.882
https://doi.org/10.1016/j.neures.2007.06.882